CRISPR/Cas9 targeting of passenger single nucleotide variants in haploinsufficient or essential genes expands cancer therapy prospects

Nakyoung Lee, Seung‐Bin Cha, Myung Joon Oh et al.|Scientific Reports|2024

Cited by 3